Collegium Pharmaceutical, Inc. (COLL)

New Strong Sell Stocks for October 7th

Collegium Launches "Start Talking ADHD" with Practical Support to Help Families Navigate Care, School and Everyday Life

Collegium Pharmaceutical, Inc. (COLL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Collegium to Participate in Upcoming Investor Conferences

44,493 Shares in Collegium Pharmaceutical, Inc. $COLL Purchased by Freestone Grove Partners LP

BlackRock Inc. Takes $196.97 Million Position in Collegium Pharmaceutical, Inc. $COLL

A Look at Collegium Pharmaceutical Inc (COLL) After 3.9% Decline -- GF Value $47.17 vs Price $26.39

Collegium Announces $50 Million Accelerated Share Repurchase Program

Avenue Therapeutics (NASDAQ:ATXI) and Collegium Pharmaceutical (NASDAQ:COLL) Head-To-Head Survey

Collegium Pharmaceutical, Inc. (COLL) Q2 2026 Earnings Call Transcript

Collegium Pharmaceutical (COLL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Collegium Pharmaceutical (COLL) Beats Q2 Earnings and Revenue Estimates

Collegium Pharmaceutical Q2 Earnings Call Highlights

Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress

Collegium Pharmaceutical: Pain Cash Flows Are Funding An ADHD Re-Rating

Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026

Bessemer Group Inc. Acquires 31,800 Shares of Collegium Pharmaceutical, Inc. $COLL

DivcoWest Welcomes Collegium Pharmaceutical to One Lincoln

Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston